Literature DB >> 1372411

Atrial paralysis in a patient with Emery-Dreifuss muscular dystrophy.

T M Marshall1, V F Huckell.   

Abstract

Emery-Dreifuss disease is a benign X-linked muscular dystrophy characterized by a distinct pattern of muscle weakness, which is of insidious onset and slow progression. It is associated with atrial paralysis that results in sudden death in early adulthood if left untreated. The authors report the documentation of electrical and mechanical silence confined to the atria in a patient with this disease. Electrocardiography and electrophysiological study document the absence of electrical atrial activity, and inability to pace the atria. Hemodynamic studies demonstrate the absence of A waves, and angiography revealed immobility of the atria. This patient has done well following the institution of permanent ventricular pacing. His brother, who also had muscular dystrophy, died a sudden cardiac death at the age of 29 after refusing medical intervention. Emery-Dreifuss muscular dystrophy is particularly worthy of recognition because of the preventable occurrence of sudden death in young patients with an otherwise excellent prognosis. Permanent ventricular pacing is indicated.

Entities:  

Mesh:

Year:  1992        PMID: 1372411     DOI: 10.1111/j.1540-8159.1992.tb03056.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  A novel de novo mutation in Lamin A/C gene in Emery Dreifuss Muscular Dystrophy patient with atrial paralysis.

Authors:  Chaerul Achmad; Almira Zada; Mardlatillah Affani; Mohammad Iqbal; Erwan Martanto; Augustine Purnomowati; Toni M Aprami
Journal:  J Atr Fibrillation       Date:  2017-04-30

2.  Cardiac dysrhythmias,cardiomyopathy and muscular dystrophy in patients with Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy type 1B.

Authors:  Jong-Seo Hong; Chang-Seok Ki; Jong-Won Kim; Yeon-Lim Suh; June Soo Kim; Kyung Kee Baek; Byoung Joon Kim; Kyoung Ju Ahn; Duk-Kyung Kim
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.